• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内质网亚型在癌症生物学和治疗中的不同作用。

The different roles of ER subtypes in cancer biology and therapy.

机构信息

Center for Nuclear Receptors and Cell Signalling, Department of Biology and Biochemistry, University of Houston, Houston 77204, Texas, USA.

出版信息

Nat Rev Cancer. 2011 Jul 22;11(8):597-608. doi: 10.1038/nrc3093.

DOI:10.1038/nrc3093
PMID:21779010
Abstract

By eliciting distinct transcriptional responses, the oestrogen receptors (ERs) ERα and ERβ exert opposite effects on cellular processes that include proliferation, apoptosis and migration and that differentially influence the development and the progression of cancer. Perturbation of ER subtype-specific expression has been detected in various types of cancer, and the differences in the expression of ERs are correlated with the clinical outcome. The changes in the bioavailability of ERs in tumours, together with their specific biological functions, promote the selective restoration of their activity as one of the major therapeutic approaches for hormone-dependent cancers.

摘要

通过引发不同的转录反应,雌激素受体 (ERs) ERα 和 ERβ 对包括增殖、凋亡和迁移在内的细胞过程产生相反的影响,并对癌症的发展和进展产生不同的影响。在各种类型的癌症中都检测到 ER 亚型特异性表达的扰动,并且 ERs 的表达差异与临床结果相关。肿瘤中 ER 生物利用度的变化及其特定的生物学功能,促进了其活性的选择性恢复,这是激素依赖性癌症的主要治疗方法之一。

相似文献

1
The different roles of ER subtypes in cancer biology and therapy.内质网亚型在癌症生物学和治疗中的不同作用。
Nat Rev Cancer. 2011 Jul 22;11(8):597-608. doi: 10.1038/nrc3093.
2
Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.雌激素受体通向雌激素反应元件的途径:反式激活功能-1作为雌激素受体(ER)β介导的ERα转录抑制的关键要素。
J Steroid Biochem Mol Biol. 2007 May;104(3-5):110-22. doi: 10.1016/j.jsbmb.2007.03.002. Epub 2007 Mar 12.
3
Estrogen receptors similarly mediate the effects of 17β-estradiol on cellular responses but differ in their potencies.雌激素受体同样介导 17β-雌二醇对细胞反应的影响,但效力不同。
Endocrine. 2011 Feb;39(1):48-61. doi: 10.1007/s12020-010-9411-8. Epub 2010 Nov 11.
4
Differential expression of estrogen receptor subtypes and variants in ovarian cancer: effects on cell invasion, proliferation and prognosis.卵巢癌中雌激素受体亚型和变体的差异表达:对细胞侵袭、增殖和预后的影响。
BMC Cancer. 2017 Aug 31;17(1):606. doi: 10.1186/s12885-017-3601-1.
5
[Estrogen receptor Beta isoforms -- functions and clinical relevance in breast cancer].[雌激素受体β亚型——在乳腺癌中的功能及临床相关性]
Zentralbl Gynakol. 2005 Aug;127(4):228-34. doi: 10.1055/s-2005-836563.
6
Estrogen receptor subtypes dictate the proliferative nature of the mammary gland.雌激素受体亚型决定乳腺的增殖特性。
J Endocrinol. 2018 Jun;237(3):323-336. doi: 10.1530/JOE-17-0582. Epub 2018 Apr 10.
7
Estrogen Receptors alpha and beta as determinants of gene expression: influence of ligand, dose, and chromatin binding.雌激素受体α和β作为基因表达的决定因素:配体、剂量和染色质结合的影响
Mol Endocrinol. 2008 May;22(5):1032-43. doi: 10.1210/me.2007-0356. Epub 2008 Feb 7.
8
Global analysis of estrogen receptor beta binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor alpha for target gene regulation.雌激素受体β与乳腺癌细胞基因组的全局分析揭示了其与雌激素受体α在靶基因调控方面的广泛相互作用。
BMC Genomics. 2011 Jan 14;12:36. doi: 10.1186/1471-2164-12-36.
9
ERbeta in breast cancer--onlooker, passive player, or active protector?雌激素受体β在乳腺癌中——旁观者、被动参与者还是积极保护者?
Steroids. 2008 Oct;73(11):1039-51. doi: 10.1016/j.steroids.2008.04.006. Epub 2008 Apr 20.
10
Estrogen receptor (ER)beta isoforms rather than ERalpha regulate corticotropin-releasing hormone promoter activity through an alternate pathway.雌激素受体(ER)β亚型而非ERα通过一条替代途径调节促肾上腺皮质激素释放激素启动子活性。
J Neurosci. 2004 Nov 24;24(47):10628-35. doi: 10.1523/JNEUROSCI.5540-03.2004.

引用本文的文献

1
Analyzing the mechanism of rhubarb in the treatment of cervical cancer based on network pharmacology and molecular docking technology.基于网络药理学和分子对接技术分析大黄治疗宫颈癌的作用机制。
Sci Rep. 2025 Aug 16;15(1):30027. doi: 10.1038/s41598-025-15827-7.
2
Nuclear Receptors in Bladder Cancer: Insights into miRNA-Mediated Regulation and Potential Therapeutic Implications.膀胱癌中的核受体:对miRNA介导的调控及潜在治疗意义的见解
Int J Mol Sci. 2025 Jul 29;26(15):7340. doi: 10.3390/ijms26157340.
3
Targeting DNA Damage Response-Mediated Resistance in Non-Small Cell Lung Cancer: From Mechanistic Insights to Drug Development.

本文引用的文献

1
Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancer.激酶组筛选鉴定雌激素受体调节剂,发现 LMTK3 是乳腺癌的一个新的治疗靶点。
Nat Med. 2011 Jun;17(6):715-9. doi: 10.1038/nm.2351. Epub 2011 May 22.
2
Elevated expression of CUEDC2 protein confers endocrine resistance in breast cancer.CUEDC2 蛋白表达升高赋予乳腺癌内分泌抵抗。
Nat Med. 2011 Jun;17(6):708-14. doi: 10.1038/nm.2369. Epub 2011 May 15.
3
Estrogen regulates tumor growth through a nonclassical pathway that includes the transcription factors ERβ and KLF5.
靶向非小细胞肺癌中DNA损伤反应介导的耐药性:从机制洞察到药物开发
Curr Oncol. 2025 Jun 23;32(7):367. doi: 10.3390/curroncol32070367.
4
Aging Effects on Absolute and Relative Estrogen Receptor Variant Gene Expression Levels in Male Versus Female Rat Ventromedial Hypothalamic Nucleus Growth Hormone-Releasing Hormone Neurons.衰老对雄性和雌性大鼠腹内侧下丘脑核生长激素释放激素神经元中雌激素受体变异基因绝对和相对表达水平的影响。
J Integr Neurosci. 2025 Jun 23;24(6):38142. doi: 10.31083/JIN38142.
5
Targeting the Undruggable: Recent Progress in PROTAC-Induced Transcription Factor Degradation.靶向不可成药靶点:PROTAC诱导的转录因子降解研究的最新进展
Cancers (Basel). 2025 Jun 3;17(11):1871. doi: 10.3390/cancers17111871.
6
Endocrine therapy for endometrial cancer: traditional approaches and novel targets.子宫内膜癌的内分泌治疗:传统方法与新靶点
Front Oncol. 2025 May 5;15:1570011. doi: 10.3389/fonc.2025.1570011. eCollection 2025.
7
Failure to Suppress Progression in Clear Cell Renal Cell Carcinoma Associated with NCOA7 Low Expression Revealed Through Radiogenomic Analysis.通过放射基因组分析揭示NCOA7低表达与透明细胞肾细胞癌进展抑制失败相关
Genes (Basel). 2025 Mar 28;16(4):386. doi: 10.3390/genes16040386.
8
Antiproliferative Role of Natural and Semi-Synthetic Tocopherols on Colorectal Cancer Cells Overexpressing the Estrogen Receptor β.天然和半合成生育酚对过表达雌激素受体β的结肠癌细胞的抗增殖作用
Int J Mol Sci. 2025 Mar 5;26(5):2305. doi: 10.3390/ijms26052305.
9
Mechanism of action of genistein on breast cancer and differential effects of different age stages.染料木黄酮对乳腺癌的作用机制及不同年龄阶段的差异效应。
Pharm Biol. 2025 Dec;63(1):141-155. doi: 10.1080/13880209.2025.2469607. Epub 2025 Feb 25.
10
Multimodal data integration in early-stage breast cancer.早期乳腺癌的多模态数据整合
Breast. 2025 Apr;80:103892. doi: 10.1016/j.breast.2025.103892. Epub 2025 Jan 28.
雌激素通过非经典途径调节肿瘤生长,该途径包括转录因子 ERβ 和 KLF5。
Sci Signal. 2011 Apr 12;4(168):ra22. doi: 10.1126/scisignal.2001551.
4
Bortezomib enhances the efficacy of fulvestrant by amplifying the aggregation of the estrogen receptor, which leads to a proapoptotic unfolded protein response.硼替佐米通过增强雌激素受体的聚集来增强氟维司群的疗效,从而导致促凋亡的未折叠蛋白反应。
Clin Cancer Res. 2011 Apr 15;17(8):2292-300. doi: 10.1158/1078-0432.CCR-10-1745. Epub 2011 Feb 3.
5
Combined analysis of estrogen receptor beta-1 and progesterone receptor expression identifies lung cancer patients with poor outcome.联合分析雌激素受体β-1 和孕激素受体表达可识别预后不良的肺癌患者。
Clin Cancer Res. 2011 Jan 1;17(1):154-64. doi: 10.1158/1078-0432.CCR-10-0992. Epub 2010 Nov 9.
6
Remarks on Oöphorectomy in the Treatment of Cancer of the Breast.关于卵巢切除术治疗乳腺癌的论述
Br Med J. 1899 Feb 4;1(1988):257-62. doi: 10.1136/bmj.1.1988.257.
7
Phosphorylation of estrogen receptor beta at serine 105 is associated with good prognosis in breast cancer.雌激素受体β丝氨酸 105 磷酸化与乳腺癌的良好预后相关。
Am J Pathol. 2010 Sep;177(3):1079-86. doi: 10.2353/ajpath.2010.090886. Epub 2010 Aug 9.
8
Estrogen receptor beta decreases survival of p53-defective cancer cells after DNA damage by impairing G₂/M checkpoint signaling.雌激素受体β通过损伤 G₂/M 检验点信号降低 p53 缺陷型癌细胞在 DNA 损伤后的存活率。
Breast Cancer Res Treat. 2011 Jun;127(2):417-27. doi: 10.1007/s10549-010-1011-z. Epub 2010 Jul 10.
9
Expression of estrogen receptor beta predicts a clinical response and longer progression-free survival after treatment with EGFR-TKI for adenocarcinoma of the lung.雌激素受体β的表达可预测 EGFR-TKI 治疗肺腺癌的临床反应和更长的无进展生存期。
Lung Cancer. 2011 Mar;71(3):350-5. doi: 10.1016/j.lungcan.2010.06.009. Epub 2010 Jul 8.
10
Estrogen receptor beta2 and beta5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion.雌激素受体β2 和β5 与前列腺癌的预后不良相关,并促进癌细胞迁移和侵袭。
Endocr Relat Cancer. 2010 Jun 25;17(3):675-89. doi: 10.1677/ERC-09-0294. Print 2010 Sep.